Chris Dall | News Reporter | CIDRAP NewsMay 15, 2020One of the studies is the first published randomized controlled trial on the drug for COVID-19.
Studies find further lack of COVID benefit from hydroxychloroquine
More from COVID-19More posts in COVID-19 »